Rayner announces world’s first implantations of RayOne EMV Toric
Posted on 16/09/2022
16 September 2022. Worthing, United Kingdom – Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, today announced that the world’s first implantations of RayOne EMV Toric had been performed by two highly respected surgeons from the UK.
RayOne EMV Toric is the awaited toric variant of Rayner’s popular RayOne EMV enhanced monofocal IOL that was developed in collaboration with world-renowned surgeon, Professor Graham Barrett.
The RayOne EMV platform features a truly non-diffractive optic that provides patients with >1.5 D1,4 of high quality natural vision with an emmetropic target. Following excellent surgeon feedback for RayOne EMV’s monofocal levels of contrast sensitivity1, dysphotopsia2 and high levels of patient satisfaction3, RayOne EMV Toric has been designed to allow surgeons to additionally correct corneal astigmatism with a wide selection of IOL plane cylinders.
The world’s first implantations of RayOne EMV Toric were performed by Mr Allon Barsam (OCL Vision, London) and Mr Amir Hamid (Optegra, London).
Commenting on being first implanters of RayOne EMV Toric:
Mr Barsam –
“When a patient is not suitable for a trifocal IOL or does not demand total spectacle independence then RayOne EMV is my go-to enhanced lens option. RayOne EMV reliably provides my patients with excellent distance and intermediate vision, as well as functional near vision for everyday tasks, with no additional chair time over a standard monofocal lens. Consequently, I jumped at the opportunity to implant the new toric model.”
Mr Hamid –
“Enhanced monofocal IOLs are one of the most exciting areas of ophthalmology at the moment; coupling distance and intermediate spectacle independence with low levels of dysphotopsia is highly desirable for patients. I am a big user of toric lenses so was excited to be a first implanter of RayOne EMV Toric. The bilateral surgeries went smoothly, and I look forward to sharing my clinical results in the coming months.”
On the launch of RayOne EMV Toric, Rayner CEO, Tim Clover remarked:
“Since launching RayOne EMV in 2020, one of the most frequent questions asked to me by surgeons has been ‘when will be the toric version be available?’. Our organisation has worked tirelessly over the last two years to develop the new toric EMV optic, which I am thrilled that we’re launching at this year’s ESCRS congress in Milan. RayOne EMV Toric is the latest premium lens in our ever-growing portfolio, supporting our mission to offer the very best visual outcomes for surgeons and their patients.”
RayOne EMV Toric will be available to order in the UK and CE certificate-accepting countries from 7th October 2022. Further country availability is subject to international regulatory approvals.
Since the implantation of the first Rayner intraocular lens by Sir Harold Ridley 1949, Rayner has continuously pioneered intraocular lens (IOL) design with a goal to improve vision and restore sight worldwide. Today, Rayner’s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.
Headquartered in Worthing, United Kingdom, Rayner markets its medical devices, pharmaceuticals and digital solutions worldwide in over 80 countries through a network of distributors and includes direct sales teams in the United Kingdom, USA, Canada, India, Poland, Australia, Germany, Austria, Switzerland, France, Italy, Spain and Portugal.
For further information and media enquiries, please contact Rayner: email@example.com
Not all Rayner products are approved for sale in every country.
Please contact your local Rayner distributor for details of which products are available in your area.
©2022 Rayner, all rights reserved. Rayner, RayOne, Sulcoflex and RayPRO are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539. EC 2022-207
- Ferreira T. et al. Clinical outcomes comparison EMV vs. Eyhance, Symfony, Vivity. Presented at Winter ESCRS 2022.
- RayOne EMV: First Clinical Results, Rayner. Oct 2020.
- Rayner RayPRO, data on file.
- Rayner, data on file.